Mucosal Vaccines Protect Mice from Viruses, Cancer
Mucosal Vaccines Protect Mice from Viruses, Cancer
Scientists use a protein found in mucus membranes to ferry vaccines to the lymph nodes.
Mucosal Vaccines Protect Mice from Viruses, Cancer
Mucosal Vaccines Protect Mice from Viruses, Cancer

Scientists use a protein found in mucus membranes to ferry vaccines to the lymph nodes.

Scientists use a protein found in mucus membranes to ferry vaccines to the lymph nodes.

vaccination
T Cell–Boosting Zika Vaccine Protects Mice from the Virus
T Cell–Boosting Zika Vaccine Protects Mice from the Virus
Ruth Williams | May 12, 2021
By avoiding the production of antibodies, something vaccines ordinarily induce, the immunization sidesteps the problem of antibody-dependent enhancement, which can amplify infection by a similar virus and is known to occur with dengue and Zika.
What Scientists Know About the B.1.617 Coronavirus Variant
What Scientists Know About the B.1.617 Coronavirus Variant
Shawna Williams | May 3, 2021
While some experts speculate the variant could be partially responsible for India’s current surge in SARS-CoV-2 infections, information about the effects of its mutations is only beginning to emerge.
Depoliticizing Science
Depoliticizing Science
Bob Grant | May 1, 2021
Politicians should of course consider and respect the latest research findings in crafting policy, but elected officials should honor the scientific method by letting its practitioners hash out the details of the science.
New Malaria Vaccine Shows Most Efficacy of Any to Date: Small Trial
New Malaria Vaccine Shows Most Efficacy of Any to Date: Small Trial
Catherine Offord | Apr 26, 2021
Immunization had up to 77 percent efficacy in a Phase 2 clinical study of 450 children in Burkina Faso.
Pharma, US Government Plan for COVID-19 Booster Shots
Pharma, US Government Plan for COVID-19 Booster Shots
Jef Akst | Apr 16, 2021
It’s unclear how long protections against infection will last from the initial vaccinations, and health authorities say additional jabs will likely be necessary.
Blood Clot Risk from COVID-19 Higher than After Vaccines: Study
Blood Clot Risk from COVID-19 Higher than After Vaccines: Study
Shawna Williams | Apr 16, 2021
The chance of developing cerebral venous sinus thrombosis was nearly 10 times higher in the two weeks following a diagnosis of SARS-CoV-2 infection than after receiving an mRNA vaccine, a data analysis finds.
J&J COVID-19 Vaccinations Resume After Temporary Shutdowns
J&J COVID-19 Vaccinations Resume After Temporary Shutdowns
Shawna Williams | Apr 9, 2021
Vaccinations with the Johnson & Johnson jab paused at several sites earlier this week after an unusual number of people experienced adverse reactions, but the CDC says there’s no cause for concern.
Blood Clots a Very Rare Side Effect of AstraZeneca Vaccine: EMA
Blood Clots a Very Rare Side Effect of AstraZeneca Vaccine: EMA
Catherine Offord | Apr 8, 2021
The European Medicines Agency emphasizes that the benefits of the jab in protecting against COVID-19 still far outweigh the risks.
Bile and Potatoes, 1921
Bile and Potatoes, 1921
Jef Akst | Apr 1, 2021
One hundred years after its invention, BCG has stood the test of time as a vaccine against tuberculosis.
Oxford/AstraZeneca COVID-19 Vaccine on Hold in Some Countries
Oxford/AstraZeneca COVID-19 Vaccine on Hold in Some Countries
Asher Jones | Mar 12, 2021
Rollouts of the shot have ground to a halt following reports of blood clots, but health authorities say that these fears are unfounded and vaccination programs should continue.
US Authorizes a Third COVID-19 Vaccine
US Authorizes a Third COVID-19 Vaccine
Asher Jones | Mar 1, 2021
Johnson & Johnson’s one-shot immunization could reach people’s arms as early as March 2.
Democratized Discovery
Democratized Discovery
Bob Grant | Mar 1, 2021
In a triumph for science, COVID-19 statistics are finally trending favorably in the US. We must make sure the rest of the world is not left behind.
Q&A: New Trials Tackle COVID-19 Vaccines in Pregnancy
Q&A: New Trials Tackle COVID-19 Vaccines in Pregnancy
Catherine Shaffer | Feb 25, 2021
Geeta Swamy of Duke University School of Medicine speaks with The Scientist about starting what she considers a long-overdue clinical study of COVID-19 vaccines in pregnant women.
COVID-19 Hospitalizations Tank a Month After Vaccines Roll Out
COVID-19 Hospitalizations Tank a Month After Vaccines Roll Out
Asher Jones | Feb 23, 2021
Two preliminary reports from the UK provide real-world evidence in support of the Pfizer/BioNTech and Oxford-AstraZeneca vaccines.
COVID-19 Vaccines for Pregnant Moms May Protect Newborns
COVID-19 Vaccines for Pregnant Moms May Protect Newborns
Catherine Shaffer | Feb 17, 2021
A case study finds SARS-CoV-2 antibodies in placental cord blood after maternal vaccination.
Pfizer’s COVID-19 Vaccine Reduces Viral Load: Study
Pfizer’s COVID-19 Vaccine Reduces Viral Load: Study
Asher Jones | Feb 10, 2021
Preliminary results from an Israel-based study suggest that one dose of the vaccine reduces infectiousness—a key factor in slowing virus spread.
Vaccines Versus the Mutants
Vaccines Versus the Mutants
Anthony King | Feb 8, 2021
Facing new variants of SARS-CoV-2, some vaccines may offer more robust protection or be more easily redesigned to target them.
One-Shot COVID-19 Vaccine Prevents Severe Disease
One-Shot COVID-19 Vaccine Prevents Severe Disease
Asher Jones | Jan 29, 2021
Johnson & Johnson’s vaccine is less effective at preventing COVID-19 than other approved vaccines are, but experts say it could still be an important tool in curbing the pandemic.
Moderna Developing Booster Shot for New Virus Variant B.1.351
Moderna Developing Booster Shot for New Virus Variant B.1.351
Asher Jones | Jan 25, 2021
New data suggest that the company’s approved COVID-19 vaccine protects against different virus variants, but could be less effective against the one that originated in South Africa.